CDMO Made Scientific and New Jersey Institute of Technology (NJIT) announced a partnership to co-develop graduate-level bioprocessing elective courses within NJIT's Master of Science program in Chemical and Materials Engineering.
Launching spring 2027, the course is designed to prepare the next generation of cell and gene therapy professionals, combining academic rigor with practical, hands-on experience grounded in the same standards, tools and workflows used in active CGT manufacturing environments.
Under the collaboration, Made Scientific (formerly BioCentriq) will leverage its expertise in advanced therapies and bioprocessing — along with its Made Scientific Foundry scholar program, the academic pillar of the company's workforce development & training offering — to support the creation of rigorous, industry-aligned curriculum.
Subscribe to our e-Newsletters
Stay up to date with news, articles and insights relevant to cell and gene therapy development and manufacturing. Plus, get special offers from Cell & Gene Therapy Review delivered right to your inbox!
Sign up now!